77 related articles for article (PubMed ID: 26483173)
1. High-throughput alternative splicing detection using dually constrained correspondence analysis (DCCA).
Baty F; Klingbiel D; Zappa F; Brutsche M
J Biomed Inform; 2015 Dec; 58():175-185. PubMed ID: 26483173
[TBL] [Abstract][Full Text] [Related]
2. Bevacizumab-Induced Inhibition of Angiogenesis Promotes a More Homogeneous Intratumoral Distribution of Paclitaxel, Improving the Antitumor Response.
Cesca M; Morosi L; Berndt A; Fuso Nerini I; Frapolli R; Richter P; Decio A; Dirsch O; Micotti E; Giordano S; D'Incalci M; Davoli E; Zucchetti M; Giavazzi R
Mol Cancer Ther; 2016 Jan; 15(1):125-35. PubMed ID: 26494857
[TBL] [Abstract][Full Text] [Related]
3. Angiogenesis inhibitors rechallenge in patients with advanced non-small-cell lung cancer: a pooled analysis of randomized controlled trials.
Zhao L; Li W; Zhang H; Hou N; Guo L; Gao Q
Onco Targets Ther; 2015; 8():2775-81. PubMed ID: 26491352
[TBL] [Abstract][Full Text] [Related]
4. Sustained response of malignant pericardial effusion to intrapericardial bevacizumab in an advanced lung cancer patient: a case report and literature review.
Chen D; Zhang Y; Shi F; Li M; Zhu H; Kong L; Yu J
Onco Targets Ther; 2015; 8():2767-70. PubMed ID: 26491350
[TBL] [Abstract][Full Text] [Related]
5. Platinum-Vinorelbine Induction Chemotherapy plus Bevacizumab With and Without Pemetrexed Switch Maintenance in Advanced NSCLC.
Michelsen L; Sørensen JB
Anticancer Res; 2015 Nov; 35(11):6255-9. PubMed ID: 26504059
[TBL] [Abstract][Full Text] [Related]
6. Beyond Bevacizumab: An Outlook to New Anti-Angiogenics for the Treatment of Ovarian Cancer.
Mahner S; Woelber L; Mueller V; Witzel I; Prieske K; Grimm D; Keller-V Amsberg G; Trillsch F
Front Oncol; 2015; 5():211. PubMed ID: 26500886
[TBL] [Abstract][Full Text] [Related]
7. Greater efficacy of chemotherapy plus bevacizumab compared to chemo- and targeted therapy alone on non-small cell lung cancer patients with brain metastasis.
Tang N; Guo J; Zhang Q; Wang Y; Wang Z
Oncotarget; 2016 Jan; 7(3):3635-44. PubMed ID: 26498354
[TBL] [Abstract][Full Text] [Related]
8. Early initiation of chemotherapy following complete resection of advanced ovarian cancer associated with improved survival: NRG Oncology/Gynecologic Oncology Group study.
Tewari KS; Java JJ; Eskander RN; Monk BJ; Burger RA
Ann Oncol; 2016 Jan; 27(1):114-21. PubMed ID: 26487588
[TBL] [Abstract][Full Text] [Related]
9. The SF3B1 inhibitor spliceostatin A (SSA) elicits apoptosis in chronic lymphocytic leukaemia cells through downregulation of Mcl-1.
Larrayoz M; Blakemore SJ; Dobson RC; Blunt MD; Rose-Zerilli MJ; Walewska R; Duncombe A; Oscier D; Koide K; Forconi F; Packham G; Yoshida M; Cragg MS; Strefford JC; Steele AJ
Leukemia; 2016 Feb; 30(2):351-60. PubMed ID: 26488112
[TBL] [Abstract][Full Text] [Related]
10. Mdm4: don't judge an isoform by its mRNA levels!
Bardot B; Toledo F
Aging (Albany NY); 2015 Oct; 7(10):744-5. PubMed ID: 26525060
[No Abstract] [Full Text] [Related]
11. Advanced lung adenocarcinoma with spinal cord metastasis successfully treated with second EGFR-TKI treatment: a case report and literature review.
Li X; Yang H; Zhao J; Gao H
Onco Targets Ther; 2015; 8():2739-43. PubMed ID: 26491347
[TBL] [Abstract][Full Text] [Related]
12. Targeted therapies for treatment of non-small cell lung cancer--Recent advances and future perspectives.
Minguet J; Smith KH; Bramlage P
Int J Cancer; 2016 Jun; 138(11):2549-61. PubMed ID: 26537995
[TBL] [Abstract][Full Text] [Related]
13. Defective histone supply causes changes in RNA polymerase II elongation rate and cotranscriptional pre-mRNA splicing.
Jimeno-González S; Payán-Bravo L; Muñoz-Cabello AM; Guijo M; Gutierrez G; Prado F; Reyes JC
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14840-5. PubMed ID: 26578803
[TBL] [Abstract][Full Text] [Related]
14. RNA splicing, cell signaling, and response to therapies.
Abou Faycal C; Gazzeri S; Eymin B
Curr Opin Oncol; 2016 Jan; 28(1):58-64. PubMed ID: 26575690
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of TAS-102 in the treatment of gastrointestinal malignancies.
Peters GJ
Ther Adv Med Oncol; 2015 Nov; 7(6):340-56. PubMed ID: 26557901
[TBL] [Abstract][Full Text] [Related]
16. Long-range RNA pairings contribute to mutually exclusive splicing.
Yue Y; Yang Y; Dai L; Cao G; Chen R; Hong W; Liu B; Shi Y; Meng Y; Shi F; Xiao M; Jin Y
RNA; 2016 Jan; 22(1):96-110. PubMed ID: 26554032
[TBL] [Abstract][Full Text] [Related]
17. Anti-VEGF treatment improves neurological function and augments radiation response in NF2 schwannoma model.
Gao X; Zhao Y; Stemmer-Rachamimov AO; Liu H; Huang P; Chin S; Selig MK; Plotkin SR; Jain RK; Xu L
Proc Natl Acad Sci U S A; 2015 Nov; 112(47):14676-81. PubMed ID: 26554010
[TBL] [Abstract][Full Text] [Related]
18. Clinical Practice Patterns in Chemotherapeutic Treatment Regimens for Metastatic Colorectal Cancer.
McLean J; Rho YS; Kuruba G; Mamo A; Gilabert M; Kavan T; Panasci L; Melnychuk D; Batist G; Kavan P
Clin Colorectal Cancer; 2016 Jun; 15(2):135-40. PubMed ID: 26553578
[TBL] [Abstract][Full Text] [Related]
19. The use of combinations of monoclonal antibodies in clinical oncology.
Henricks LM; Schellens JH; Huitema AD; Beijnen JH
Cancer Treat Rev; 2015 Dec; 41(10):859-67. PubMed ID: 26547132
[TBL] [Abstract][Full Text] [Related]
20. Metastatic Colorectal Cancer: A Systematic Review of the Value of Current Therapies.
Goldstein DA; Zeichner SB; Bartnik CM; Neustadter E; Flowers CR
Clin Colorectal Cancer; 2016 Mar; 15(1):1-6. PubMed ID: 26541320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]